Double attack: surgery plus laser zaps deadly brain tumors
NCT ID NCT07384884
First seen Feb 03, 2026 · Last updated Jun 19, 2026 · Updated 26 times
Summary
This study tests a new approach for a rare and aggressive brain tumor called butterfly glioblastoma, which crosses both sides of the brain and has a very poor outlook. The treatment combines open surgery to remove as much tumor as possible from one side, followed by a minimally invasive laser therapy to destroy the remaining tumor on the other side. The goal is to improve survival and preserve brain function, with 12 participants being closely monitored for cognitive and quality-of-life outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GBM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King's College NHS Foundation Trust
London, SE5 9RS, United Kingdom
Contact Phone: •••-•••-••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgery and laser interstitial thermal therapy (LITT)
What this could lead to
If successful, this combined approach could offer a new treatment option for patients with butterfly glioblastoma, potentially extending survival and reducing brain damage compared to current methods.
What could go wrong
This is a very early, small trial with only 12 participants, so results may not apply to all patients. The procedure carries risks like infection, bleeding, or stroke, and the tumor may still progress.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.